Infinimmune Raises $75M Series A to Advance Antibody Drugs
Alameda, Calif.-based Infinimmune has raised $75 million in Series A financing co-led by Regeneron Ventures and Playground Global with participation... Read More
The post Infinimmune Raises $75M Series A to Advance Antibody Drugs appeared first on citybiz.